FO

Fonar CorpNASDAQ FONR Stock Report

Last reporting period 30 Sep, 2024

Updated 18 Nov, 2024

Last price

Market cap $B

0.109

Micro

Exchange

XNAS - Nasdaq

FONR Stock Analysis

FO

Neutral

Based on Eyestock quantitative analysis, FONR`s fundamental data and valuation indicate an investment grade of Neutral at the current time.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

83/100

Moderate score

Upside

To determine whether the current price is a reasonable to buy a stock, we compare it to our estimate of fair value. The more undervalued a stock is, the higher the upside.

10.2 %

Undervalued

Market cap $B

0.109

Dividend yield

Shares outstanding

6.645 B

Fonar Corporation is engaged in the research, development, production and marketing of magnetic resonance imaging (MRI) for the detection and diagnosis of human diseases. The Company operates through two segments: manufacturing and the servicing of medical equipment and management of diagnostic imaging centers. It offers Upright MRI, which is used to scan any part of the body. The Upright MRI allows patients to be scanned in various conditions, such as standing, sitting, bending or lying down in any position. The Company’s products and services include the FONAR 360° and the OPEN SKY MRI.

View Section: Eyestock Rating